Insider: Boulding Mark Elliott EXEC. VP AND CLO - PTC THERAPEUTICS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 103,901 | 0 | 103,901 |
| Value | $6,009,633.84 | $0.00 | $6,009,633.84 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 09/12/2025 | DDS | 905 | Direct | COM | $61.21 | $55,395.05 | 103,901 |
| 09/12/2025 | DDS | 22,117 | Direct | COM | $61.33 | $1,356,435.61 | 104,445 |
| 09/12/2025 | DDS | 544 | Direct | COM | $62.09 | $33,776.96 | 103,901 |
| 09/12/2025 | DDS | 1,019 | Direct | COM | $61.31 | $62,474.89 | 103,901 |
| 09/11/2025 | DDS | 17,838 | Direct | COM | $61.00 | $1,088,118.00 | 103,901 |
| 09/11/2025 | DDS | 2,470 | Direct | COM | $61.00 | $150,670.00 | 103,901 |
| 09/11/2025 | DDS | 2,356 | Direct | COM | $61.00 | $143,716.00 | 103,901 |
| 08/15/2025 | DDS | 2,813 | Direct | COM | $48.58 | $136,655.54 | 103,901 |
| 05/16/2025 | DDS | 883 | Direct | COM | $46.02 | $40,635.66 | 103,901 |
| 05/15/2025 | DDS | 1,929 | Direct | COM | $46.18 | $89,081.22 | 103,901 |
| 03/12/2025 | DDS | 13,126 | Direct | COM | $53.31 | $699,747.06 | 103,901 |
| 03/12/2025 | DDS | 2,395 | Direct | COM | $53.23 | $127,485.85 | 103,901 |
| 03/11/2025 | DDS | 5,662 | Direct | COM | $53.02 | $300,199.24 | 103,901 |
| 03/11/2025 | DDS | 1,719 | Direct | COM | $53.01 | $91,124.19 | 103,901 |
| 03/10/2025 | DDS | 11,398 | Direct | COM | $53.12 | $605,461.76 | 103,901 |
| 03/10/2025 | DDS | 45,392 | Direct | COM | $53.15 | $2,412,584.80 | 103,901 |
| 03/10/2025 | DDS | 3,487 | Direct | COM | $52.24 | $182,160.88 | 111,663 |
| 03/10/2025 | DDS | 7,762 | Direct | COM | $53.05 | $411,774.10 | 103,901 |
| 02/20/2025 | DDS | 1,614 | Direct | COM | $50.12 | $80,900.14 | 103,901 |
| 02/19/2025 | DDS | 1,333 | Direct | COM | $50.10 | $66,777.97 | 105,515 |
| 01/08/2025 | DDS | 1,998 | Direct | COM | $44.50 | $88,911.00 | 106,848 |
| 01/07/2025 | DDS | 1,543 | Direct | COM | $45.34 | $69,959.62 | 108,846 |
| 12/03/2024 | DDS | 1,405 | Direct | COM | $54.05 | $75,940.25 | 92,389 |
| 12/03/2024 | DDS | 600 | Direct | COM | $53.04 | $31,824.00 | 92,389 |
| 12/03/2024 | DDS | 6,315 | Direct | COM | $53.14 | $335,579.10 | 93,794 |
| 1 2 3 4 5 Next Last You are at page 1 of 5 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research